Nasir Usman Nakakana, Bandyopadhyay Ananda Sankar, Montagnani Francesca, Akite Jacqueline Elaine, Mungu Etaluka Blanche, Uche Ifeanyi Valentine, Ismaila Ahmed Mohammed
a Department of Pediatrics , Usmanu Danfodio University Teaching Hospital , Sokoto , Nigeria.
b Novartis Vaccines Academy , Siena , Italy.
Hum Vaccin Immunother. 2016 Mar 3;12(3):658-63. doi: 10.1080/21645515.2015.1088617.
Nigeria has made tremendous strides towards eliminating polio and has been free of wild polio virus (WPV) for more than a year as of August 2015. However, sustained focus towards getting rid of all types of poliovirus by improving population immunity and enhancing disease surveillance will be needed to ensure it sustains the polio-free status. We reviewed the pertinent literature including published and unpublished, official reports and working documents of the Global Polio Eradication Initiative (GPEI) partners as well as other concerned organizations. The literature were selected based on the following criteria: published in English Language, published after year 2000, relevant content and conformance to the theme of the review and these were sorted accordingly. The challenges facing the Polio Eradication Initiative (PEI) in Nigeria were found to fall into 3 broad categories viz failure to vaccinate, failure of the Oral Polio Vaccine (OPV) and epidemiology of the virus. Failure to vaccinate resulted from insecurity, heterogeneous political support, programmatic limitation in implementation of vaccination campaigns, poor performance of vaccination teams in persistently poor performing Local Government areas and sporadic vaccine refusals in Northern Nigeria. Sub optimal effectiveness of OPV in some settings as well as the rare occurrence of VDPVs associated with OPV type 2 in areas of low immunization coverage were also found to be key issues. Some of the innovations which helped to manage the threats to the PEI include a strong government accountability frame work, change from type 2 containing OPV to bi valent OPVs for supplementary immunization activities (SIA), enhancing environmental surveillance in key states (Sokoto, Kano and Borno) along with an overall improvement in SIA quality. There has been an improvement in coverage of routine immunization and vaccination campaigns, which has resulted in Nigeria being removed from the list of endemic countries following an absence of new cases for an entire year as of September 2015. However, the last mile remains to be crossed and there is need to further improve and sustain the momentum to complete the journey toward polio elimination.
尼日利亚在消除脊髓灰质炎方面取得了巨大进展,截至2015年8月,该国已超过一年未出现野生脊髓灰质炎病毒(WPV)。然而,要确保维持无脊髓灰质炎状态,仍需持续关注通过提高人群免疫力和加强疾病监测来消除所有类型的脊髓灰质炎病毒。我们查阅了相关文献,包括已发表和未发表的、全球根除脊髓灰质炎行动(GPEI)合作伙伴以及其他相关组织的官方报告和工作文件。这些文献根据以下标准进行选择:以英文发表、2000年后发表、内容相关且符合综述主题,并据此进行了分类。研究发现,尼日利亚根除脊髓灰质炎行动(PEI)面临的挑战主要分为三大类,即未接种疫苗、口服脊髓灰质炎疫苗(OPV)失效以及病毒流行病学问题。未接种疫苗是由于不安全因素、政治支持的不均衡、疫苗接种运动实施过程中的计划限制、在持续表现不佳的地方政府地区疫苗接种团队表现不佳以及尼日利亚北部偶尔出现的疫苗拒绝情况。此外,还发现OPV在某些情况下效果欠佳,以及在免疫覆盖率较低地区与2型OPV相关的疫苗衍生脊髓灰质炎病毒(VDPV)罕见出现也是关键问题。一些有助于应对PEI威胁的创新措施包括强有力的政府问责框架、在补充免疫活动(SIA)中从含2型的OPV改为二价OPV、加强关键州(索科托、卡诺和博尔诺)的环境监测以及全面提高SIA质量。常规免疫和疫苗接种运动的覆盖率有所提高,这使得尼日利亚在截至2015年9月一整年没有新病例后,被从流行国家名单中除名。然而,最后一公里仍有待跨越,需要进一步改进并保持势头,以完成消除脊髓灰质炎的征程。